Building robust SEC methods - Develop once, transfer with confidence

Pá, 20.11.2026 16:00 CET
Zjistěte, jak vyvíjet robustní SEC metody pro proteinová léčiva, využívat SEC-MALS při charakterizaci proteinů a usnadnit přenos metod do rutinní kontroly kvality.
SelectScience: Building robust SEC methods - Develop once, transfer with confidence
SelectScience: Building robust SEC methods - Develop once, transfer with confidence

A robust size exclusion chromatography (SEC) method needs to perform beyond development. For protein therapeutics, successfully transferring SEC methods into routine environments such as quality control (QC) requires the right selectivity, reproducibility, and long-term robustness from the start.

In this SelectScience® TechTalk, experts from Waters will explore practical strategies for developing SEC methods with successful method transfer and routine deployment in mind. The session will examine how SEC coupled with multi-angle light scattering (SEC-MALS) provides complementary insights for protein characterization, alongside method development considerations that can help strengthen assay performance.

By attending this TechTalk, in just 20 minutes, you will gain practical insights into using modern liquid chromatography (LC) technologies to reduce method transfer risk, simplify the transition into routine QC, and build more robust SEC workflows for protein therapeutic characterization.

Certificate of attendance

If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing [email protected].

TechTalk details
  • Cost: Free to attend
  • Location: Online
  • Duration: 20 minutes

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.

Who should attend?

This event is perfect for:

  • Analytical development scientists
  • Protein characterization scientists
  • Biopharmaceutical method developers
  • Quality control analysts and managers
  • CMC scientists
    Biopharmaceutical researchers involved in protein therapeutic development and commercialization
  • Laboratory managers responsible for analytical method transfer and lifecycle management

What will this webinar cover?

  • The most common pitfalls when developing SEC methods intended for QC use.
  • How column selection, mobile phase conditions, and lifecycle-based method development influence long-term robustness.
  • How SEC-MALS and other orthogonal techniques can support method development and successful transfer into regulated QC environments.

Join the TechTalk to get answers to these questions:

  • What are the most common pitfalls when developing SEC methods for QC use?
  • How do column selection and mobile phase conditions affect long-term method robustness?
  • How can lifecycle-based method development support reliable QC deployment?
  • How can SEC-MALS and other orthogonal techniques improve method understanding and development decisions?
  • What factors, including modern LC platforms, help SEC methods transfer successfully into regulated QC environments?

Presenter: Sophia Woyda (Senior Manager, Product Marketing and Enablement Next Generation LC Systems, Waters Corporation)

Sophia Woyda is Senior Manager of Product Marketing and Enablement for the Next Generation LC Systems portfolio at Waters Corporation, leading marketing strategy, commercialization, and enablement for Waters' latest and future liquid chromatography platforms. Bringing together research, engineering, application science, and global partners, Sophia centers system design, performance, and intelligence and to drive adoption and success of new LC technologies across analytical laboratories. Prior to joining Waters, Sophia specialized to next-generation technologies across industries. 

Presenter: Karyssa Edwards (Senior Product Management, Waters Corporation)

Karyssa Edwards is a Senior Product Manager at Waters Corporation, where she oversees the bioseparations sizing portfolio, including size exclusion chromatography (SEC) and slalom chromatography columns. In this role, she is responsible for driving product development, commercialization, and ongoing portfolio success. Prior to joining Waters, Karyssa spent nearly a decade as an Analytical Development Scientist, specializing in the development and qualification of analytical methods for quality control and biophysical characterization of various biomolecules.

Presenter: Bud Halim (Principal Product Marketing Manager, Waters Corporation)

Bud Halim, Ph.D., is a Principal Product Marketing Manager at Waters, focused on light scattering and field-flow fractionation. A physical chemist by training, he brings more than a decade of experience spanning the lab bench and the marketplace in scientific instrumentation. Bud bridges advanced analytical technology and practical insight for scientists working with peptides, biologics, lipid nanoparticles (LNPs), and viral vectors.

SelectScience
LinkedIn Logo